Skip to main content
    C

    Connect Biopharma Holdings Ltd (CNTB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.64
    -0.03 (-5.05%)

    Market Cap: $42.65M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Connect Biopharma Holdings Ltd (CNTB) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Connect Biopharma Holdings are ImageneBio (IMA), Barinthus Biotherapeutics (BRNS) and XBiotech (XBIT). By market cap, Connect Biopharma Holdings ranks 7th of the 13 companies on this page; Corbus Pharmaceuticals Holding (CRBP) is the largest at $69.86M.

    Peer Comparison

    CNTB's revenue growth of 5667.0% is above the peer median of -1.4%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Connect Biopharma Holdings (CNTB)$42.65MN/A13.6x0.0%N/A5667.0%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    Barinthus Biotherapeutics plc (BRNS)$30.23MN/AN/A0.0%N/A-100.0%0.00%
    XBiotech Inc (XBIT)$59.76MN/AN/A0.0%N/A-93.3%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    Biomea Fusion Inc (BMEA)$42.31MN/AN/A0.0%N/A0.0%0.00%
    Instil Bio Inc. (TIL)$41.23MN/AN/A0.0%-11.9%0.0%0.00%
    Corbus Pharmaceuticals Holding (CRBP)$69.86MN/A13.9x0.0%-106.7%-100.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Werewolf Therapeutics Inc (HOWL)$47.64MN/A2.3x-164.8%N/A-100.0%0.00%
    Peer median$42.77MN/A13.9x0.0%-106.7%-1.4%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Connect Biopharma Holdings, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    ImageneBio, Inc. (IMA)
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    Barinthus Biotherapeutics plc (BRNS)
    Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system...
    BRNS competitors
    XBiotech Inc (XBIT)
    XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases.
    XBIT competitors
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    iBio, Inc. Common Stock (IBIO)
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors
    Biomea Fusion Inc (BMEA)
    Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat...
    BMEA competitors
    Instil Bio Inc. (TIL)
    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients.
    TIL competitors
    Corbus Pharmaceuticals Holding (CRBP)
    Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target...
    CRBP competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    NextCure Inc (NXTC)
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors
    Werewolf Therapeutics Inc (HOWL)
    Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer.
    HOWL competitors

    Frequently Asked Questions About CNTB

    Who are Connect Biopharma Holdings' main competitors?

    The companies most similar to Connect Biopharma Holdings include ImageneBio (IMA), Barinthus Biotherapeutics (BRNS), XBiotech (XBIT), INmune Bio (INMB) and iBio, Inc. Common Stock (IBIO), listed from the closest match.

    Who is Connect Biopharma Holdings' biggest competitor?

    Corbus Pharmaceuticals Holding (CRBP) is the largest of the similar companies at $69.86M; ImageneBio (IMA) is the closest match by business profile, size, sector and industry.

    How does CNTB stock compare with its competitors?

    CNTB's P/S is 13.6x against a peer median of 13.9x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Connect Biopharma Holdings' competitors pays a higher dividend?

    Connect Biopharma Holdings pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Connect Biopharma Holdings bigger than its competitors?

    No. Connect Biopharma Holdings is 7th by market cap among the 13 companies on this page; the largest is Corbus Pharmaceuticals Holding (CRBP) at $69.86M.